COVID Kush is a modern, autoflowering variety developed through the crossing of Banana Kush and Ruderalis. The origins and historical context surrounding the creation of this strain remain undocumented, as there is currently no record of the original breeder or specific development timeline. Its development as an autoflowering cultivar prioritizes ease of cultivation, with a flowering period that lasts 95 days and a tendency toward low yields.

The chemical profile of COVID Kush is defined by a complex array of terpenes, anchored by myrcene as the dominant compound, followed by limonene, caryophyllene, and pinene. The profile continues with nerolidol, terpinolene, linalool, beta-pinene, humulene, ocimene, bisabolol, guaiol, caryophyllene-oxide, camphene, p-cymene, and geraniol. This diverse configuration likely yields a nuanced sensory experience, though its specific aromatic nuances remain a subject of consumer interpretation.

As a THC-dominant strain, COVID Kush is reported to produce effects characterized by feelings of relaxation, happiness, and an uplifted mood. Its therapeutic applications are primarily associated with the management of stress, pain, and sleep difficulties. Despite its unique genetic make-up, no notable offspring have been recorded to date, and the plant remains adaptable to both indoor and outdoor growing environments.